lx4211

  1. T

    Phase 2 Trial Of LX4211 Demonstrates Significant And Rapid Improvements In Multiple P

    Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day...
    • tD33NAt
    • Thread
    • demonstrates improvements lx4211 multiple phase rapid significant trial
    • Replies: 0
    • Forum: Health and Fitness
  2. T

    Phase 2 Trial Of LX4211 Demonstrates Significant And Rapid Improvements In Multiple P

    Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained positive results from a recently completed Phase 2 study of LX4211 in patients with type 2 diabetes mellitus. LX4211 is a once-per-day...
    • tD33NAt
    • Thread
    • demonstrates improvements lx4211 multiple phase rapid significant trial
    • Replies: 0
    • Forum: Health and Fitness
Back
Top